Study led by professor at Touro University's Nevada campus sheds light on how AIDS-causing virus enters a cell's nucleus so it can replicate, finds possible drug countermeasure

Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells

Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro

Nanoparticles, tested on mice and unveiled in peer-reviewed research, head straight to cells that are inflamed, and either ‘silence’ or edit the gene that is causing inflammation

Technion team says it has identified the T-cell mechanism that launches ‘cytokine storms,’ which have caused many coronavirus deaths

Immunotherapy needs peptides to work, but if a patient has too few, anti-cancer drugs will fall short; discovery of new type by Weizmann Institute-led team could solve problem

Scientists at Israel's Weizmann Institute find that these protective cells combat excess hormones in certain organs; when they misread the situation, illness results

Understanding role of TOX protein could pave way to restoring normal function in systems weakened by chronic disease, say researchers from Israel's Bar-Ilan University and others